These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 15153324

  • 1. Low all-cause mortality in the volunteer-based Rotterdam section of the European randomised study of screening for prostate cancer: self-selection bias?
    Otto SJ, Schröder FH, de Koning HJ.
    J Med Screen; 2004; 11(2):89-92. PubMed ID: 15153324
    [Abstract] [Full Text] [Related]

  • 2. Prostate cancer mortality in screen and clinically detected prostate cancer: estimating the screening benefit.
    van Leeuwen PJ, Connolly D, Gavin A, Roobol MJ, Black A, Bangma CH, Schröder FH.
    Eur J Cancer; 2010 Jan; 46(2):377-83. PubMed ID: 19804966
    [Abstract] [Full Text] [Related]

  • 3. Disease-specific survival of men with prostate cancer detected during the screening interval: results of the European randomized study of screening for prostate cancer-Rotterdam after 11 years of follow-up.
    Zhu X, van Leeuwen PJ, Bul M, Otto SJ, de Koning HJ, Bangma CH, Schröder FH, Roobol MJ.
    Eur Urol; 2011 Aug; 60(2):330-6. PubMed ID: 21601352
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Results and participation factors to the European Randomized study of Screening for Prostate Cancer (ERSPC) with Prostate Specific Antigen: French departments of Tarn and Hérault].
    Jegu J, Tretarre B, Grosclaude P, Rebillard X, Bataille V, Malavaud B, Iborra F, Salama G, Rischmann P, Villers A.
    Prog Urol; 2009 Jul; 19(7):487-98. PubMed ID: 19559380
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Biochemical progression rates in the screen arm compared to the control arm of the Rotterdam Section of the European Randomized Study of Screening for Prostate Cancer (ERSPC).
    Roemeling S, Roobol MJ, Gosselaar C, Schröder FH.
    Prostate; 2006 Jul 01; 66(10):1076-81. PubMed ID: 16637077
    [Abstract] [Full Text] [Related]

  • 11. Is additional testing necessary in men with prostate-specific antigen levels of 1.0 ng/mL or less in a population-based screening setting? (ERSPC, section Rotterdam).
    Roobol MJ, Roobol DW, Schröder FH.
    Urology; 2005 Feb 01; 65(2):343-6. PubMed ID: 15708050
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).
    Schröder FH.
    Can J Urol; 2005 Feb 01; 12 Suppl 1():2-6; discussion 92-3. PubMed ID: 15780157
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Screening for prostate cancer: updated experience from the Tyrol study.
    Horninger W, Berger A, Pelzer A, Klocker H, Oberaigner W, Schönitzer D, Severi G, Robertson C, Boyle P, Bartsch G.
    Can J Urol; 2005 Feb 01; 12 Suppl 1():7-13; discussion 92-3. PubMed ID: 15780158
    [Abstract] [Full Text] [Related]

  • 18. Impacts of a population-based prostate cancer screening programme on excess total mortality rates in men with prostate cancer: a randomized controlled trial.
    van Leeuwen PJ, Kranse R, Hakulinen T, Hugosson J, Tammela TL, Ciattoy S, Roobol MJ, Zappa M, de Koning HJ, Bangma CH, Moss SM, Auvinen A, Schröder FH.
    J Med Screen; 2013 Mar 01; 20(1):33-8. PubMed ID: 23390203
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Tumour features in the control and screening arm of a randomized trial of prostate cancer.
    Postma R, van Leenders AG, Roobol MJ, Schröder FH, van der Kwast TH.
    Eur Urol; 2006 Jul 01; 50(1):70-5. PubMed ID: 16434136
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.